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ABSTRACT. This research presents the synthesis and characterization of the photochemical nitric 
oxide (NO) precursor Ru(salenCO2H)(NO)Cl (I, salenCO2H = N,N'-ethylenebis(3,3’-bis-carbox-
ylsalicylideneiminato). This water-soluble ruthenium nitrosyl releases NO upon photolysis with a 
quantum yield that is pH dependent owing to the nitrosyl to nitrite conversion of that axial ligand 
at higher pH.  Also described are the water, oxygen, and thermal stability of I and the cytotoxicity 
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Introduction 
 The photochemical "uncaging" of biologically active molecular species has drawn consid-
erable interest [1], since this methodology provides the spatially specific opportunity to release 
defined concentrations of a substance such as nitric oxide (nitrogen monoxide) at a biological tar-
get. This specificity may minimize systemic side-effects while controlling the timing of such an 
event [2-6]. In this context, we [7-14] and others [15-27] have studied the photochemistry of ru-
thenium nitrosyl compounds owing to their thermal stability and their photolability toward NO 
release.  Endogenously produced NO demonstrates key bioregulator roles in mammalian physiol-
ogy (including vasodilation) [28] as well as serving as a cyto-toxin at the higher concentrations 
generated during immune response to pathogens [29-31]. Moreover, NO is a sensitizer of g-radia-
tion damage to cells, a feature that could prove valuable in the radiotherapy of hypoxic tumors 
[32-34].  Application of NO in the latter task is especially attractive given that the concomitant 
vasodilation should also increase tissue oxygenation at the targeted site and that O2 is a radiation 
sensitizer as well. However, due to NO’s promiscuous bioactivity, controlling its dosage will be 
crucial in such therapeutic applications [35], and this provides a major incentive for developing 
photo-activated NO releasing moieties (photoNORMs) [36].  
In this context, we have prepared a new photoNORM Ru(salenCO2H)(NO)Cl (1) (sa-
lenCO2H = N,N'-ethylenebis(3,3’-bis-carboxyl-salicylidene-iminato) that is water soluble, is ther-
mally stable in aerated aqueous media, and is photolabile to NO release.  Notably, water solubility 
adds the challenge of pH dependence to the photoreactivity of 1 owing to the equilibrium between 
the nitrosyl and N-nitrito forms of this ligand. Although this reversible reaction for ruthenium 
nitrosyls has long been known [37-41], the present study is to our knowledge, the first to charac-
terize the photoactivated release of NO from such a pH dependent photoNORM system. We also 
report the activity of 1 in cell toxicity and vascular reactivity studies showing that 1 has moderate 
cytotoxicity before and after irradiation in cells as well as being able to trigger vasodilation in 
mammalian aortic rings only in the presence of light with no such effects observed in the dark.  
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Results and Discussion: 
  The carboxylic acid functionalized ruthenium salen nitrosyl complex Ru(sa-
lenCO2H)(NO)Cl (1) was prepared according to the reactions outlined in Scheme 1. Details are 
presented in the Experimental Section. 
 
Scheme 1. Synthesis of Ru(salenCO2H)(NO)Cl (1): (i) trifluoroacetic acid, under argon, 4 h reflux; (ii)  0.5 equiva-
lents of ethylenediamine in ethanol, 1 h reflux; (iii) 2.3 equiv. NaH, 1 equiv. Ru(NO)Cl3 • H2O under argon in etha-
nol 4 h reflux.  
 The UV-visible spectrum of 1 in aqueous solution is quite sensitive to the pH (Figure 1). 
These reversible spectral changes can be attributed to two types of reactions, the deprotona-
tion/protonation of the two ligand carboxylic acid groups (Eq. 1) and the acid/base dependent ni-
trosyl ↔ nitrite conversion described above (Eq. 2).  Ruthenium based nitrosyl to nitrite conver-
sions have been studied by a number of researchers [37-41], who demonstrated the reaction of the 
nitrosyl electrophile (formally represented as RuII(NO+) in such complexes) with hydroxide.  
  
Figure 1. The optical spectra of Ru(salenCO2H)(NO)Cl (1) recorded in 50 mM phosphate solution at  pH 1.0 (purple 
short dashes) pH 7.04 (black solid line) and at pH  11.07 (red long dashes). At pH 7.4 the lmax appear at 229 nm (e = 
1.13 x 104 M-1 cm-1), 248 nm (1.18 x 104 M-1 cm-1) and ~ 364 nm (2.8 x 103 M-1 cm-1). 
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  (1) 
 
    (2) 
[1-NO]2–              [1-NO2]4–        
 The pH dependences of these two transformations in 1 were determined by systematically 
recording the solution spectrum at 100 separate pH values ranging from 0.5 to 11.5.  The carbox-
ylic acid/carboxylate equilibrium(a) (Eq. 1) was(were) evidenced by spectral changes at lower pH 
values. This was studied quantitatively by plotting the ratio of the absorbance at 247 nm to that at 
428 nm (Abs277/Abs428) at pH values from 0.5 to 6. A single inflection in this curve is evident 
between pH 2.9 and pH 4.3 indicative of a pKa value of ~3.65 (Figure 2-top). Since only one such 
inflection was observed, a pKa for a second carboxylic acid is not obvious.  Since it is very unlikely 
that this would occur below 0.5, the more likely explanation is that the first and second carboxylate 
pKa values are very close, and the resulting spectral changes for dissociation of the second carbox-
ylic acid occur in tandem at approximately the same pH as those seen for the first carboxylic acid 
as suggested by Eq. 1. Given that the photochemical and biological experiments reported here were 
all carried out at pH values significantly above 4, we can assume that under each set of conditions 
the carboxylates were fully dissociated.   
Figure 2-bottom is a plot of the ratio of the absorbance at 371 nm to that at 323 nm 
(Abs371/Abs323) vs. the solution pH over the range 3.5 to 11.5. This plot displays a clear inflection 
at pH 7.65, a value that is consistent with the pKa of the nitrosyl/nitrite conversion (Eq. 2) based 
on earlier observations with analogous ruthenium nitrosyls. The NO+ to NO2– conversion ([1-
NO]2– to [1-NO2]4–) was also apparent in the aqueous solution phase IR spectrum which showed 
that the nitrosyl nNO peak at 1865 cm-1 disappears when the solid is dissolved in alkaline solution 
but reappears when the solution is acidified.  
All the pH dependent changes in the UV-visible spectra are reversible, suggesting that the 
compound does not decompose readily at either low or high pH. This reversibility is consistent 
with the equilibria shown in Eqs. 1 and 2.  
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Figure 2. Top:  Relative absorbance changes for 1 over the pH range 0.5 to 6 plotted as the ratio Abs247/Abs438, where 
Abs247 is the absorbance at 247 nm and Abs438 is the absorbance at 438 nm. These are interpreted as indicating the 
pKa of the carboxylic acid functional group(s) of Ru(salenCO2H)(NO)Cl. Bottom: Spectral titration over the pH range 
3.5 to 11.5 of the absorbance ratio Abs371/Abs323 , where 371 nm is lmax for the nitrite form and 323 nm is an isosbestic 
point for all forms of 1.  This is interpreted as reflecting  the pH dependence of the N-nitrito/nitrosyl equilibrium for 
compound 1. Conditions for both experiements: [1] = ~1 x 10–4 M in 50 mM KCl solution at 298 K. 
 Photochemical studies: Photolysis of buffered aqueous solutions of 1 at lirr = 365 nm led 
to NO release as detected using a Sievers Nitric Oxide Analyzer (NOA that quantitatively 
measures NO with high sensitivity. Figure 3 shows a plot of the NO detected (in moles) versus the 
light absorbed (in Einsteins) by the reactant. This plot is linear with a slope equal to FNO.  These 
quantum yields were measured at different pH values in order to assess the effects of the pH-
dependent equilibria discussed above. The lower pH results are of particular interest, since the pH 
of cancer cells falls below 6.8 under hypoxic respiration [42]. NO photolabilization measured in 
this manner gave the modest FNO values (2.6 ±0.3) x10–3, (4.8 ±0.3) x10–3 and (5.2±0.2) x10–3 
 6 
 
Figure 3. NO release from Ru(salenCO2H)(NO)Cl (1) under 365 nm irradiation at pH 4.5 (blue diamond), 6.0 (orange 
square), 7.4 (green triangle), and 11.0 (purple circle), phosphate buffer solution (50 mM). The plot shows NO (in 
moles) produced as determined by the NOA verses the light absorbed Ia*t, where Ia is the intensity of the light absorbed 
in Einsteins per s and t is time in s).  The quantum yield FNO is the slope of the line and equals 5.3 x10–3 (pH 4.5), 2.2 
x10–3 (pH 6.0), 2.6 x10–3 (pH 7.4), and 0.5 x10–3 (pH 11.0) 
for the respective pH values 7.4, 6.0 and 4.5.  In analogy to earlier studies on ruthenium salen 
nitrosyl complexes [8,10], we interpret the principal photochemical reaction in terms of NO labili-
zation from the nitrosyl form [1-NO]2– (Eq. 3). Notably, the increased FNO values at lower pH 
correspond to the higher concentrations of the nitrosyl form [1-NO]2–  relative to the N-nitrito 
analog [1-NO2]4– as indicated by Eq. 2. Consistent with this view, it is notable that FNO is markedly 
lower at higher pH (0.9 ±0.2) x10–3 and (0.5 ±0.1) x10–3 at pH 9.0 and pH 11.0, respectively. Thus, 
it appears that NO photogeneration from the N-nitrito complex is very much less efficient than 
from the nitrosyl analog, as expected. 
    (3) 
 The ΦNO values for 1 at acidic pH are consistent with that (5 x 10–3) reported previously 
for the aquo complex [Ru(salen)(H2O)(NO)]Cl (4) in aqueous solution when irradiated at 365 nm 
[10b].  However, both are surprisingly less photolabile than is the simpler, but water insoluble, 
salen complex Ru(salen)(NO)Cl (5, salen = N, N’-ethylenebis(salicylideneiminato)) when irradi-
ated in acetonitrile at 365 nm (ΦNO = 0.13 ± 0.01) [8b].  We don't have a ready explanation for the 
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>20 fold lower quantum yields for NO release 1 and 4 in buffered aqueous media than from 5 in 
acetonitrile, unless the solvent H2O somehow accelerates nonradiative deactivation of the respon-
sible excited state(s). Lehnert and coworkers [27] noted a similar decrease in NO photolability of 
other ruthenium nitrosyl complexes in aqueous solution and pointed out that such decreases might 
affect the biological efficacy.  The quantum yield for NO release for photolysis carried out at 470 
nm with a blue LED is even smaller (FNO = 0.2 x 10-3 in pH 7.4 buffered solution, SI Fig. S1)  
 Cellular viability: The cellular toxicity of 1 was studied using the murine melanoma 
B16F10 cell line. The cells were incubated with concentrations of 1 ranging from 10 µM to 200 
µM in Roswell Park Memorial Institute 1640 medium (pH 7.4) and incubated for 4 h. The plates 
were then irradiated at 470 nm with a blue LED for 4 min or kept in the dark as a control. All 
plates were then incubated for either 24 or 48 h in the dark. The MTT assay ([40], see Experimental) 
was performed to evaluate cell viability using wells not containing 1 as the controls (Fig. 4). The 
cytotoxicity of 1 toward this cell line (B16F10) was moderate under the experimental conditions. 
For example, there is no statistical difference between the control and the cells incubated with a 
concentration of 10 µM over 24 h as determined by Tukey’s post test with cell viability at 94% 
and 97% for dark and irradiated samples.  However, at much higher concentrations (100 to 200 
µM), the cell viability after 24 and 48 h did decrease to the 50-60 % level.  For these higher con-
centration experiments, there were modest, but statistically significant, increases in cell viability 
for those cultures that had been exposed to light (SI Fig. S2).  For example, cells treated 200 µM 
1 displayed 51% survival relative to the control after 48 h, while the analogous samples that had 
been pre-irradiated with the 470 nm light had a 59% survival rate.  
 Vascular reactivity: Myography experiments were used to test the effect of Ru(sa-
lenCO2H)(NO)Cl on the contraction/dilation of rat aortic rings from which the endothelium layer 
had been removed to eliminate natural sources of NO generation. These experiments were carried 
out in pH 7.4 Krebs solution over a large range in the concentration range of 1 by the periodic 
addition of stock solutions of this compound. The initial [1] was 10-10 M and the final concentration 
was 1 x 10–4 M. When the system was kept completely in the dark, there was no effect on vascular 
relaxation at over this concentration range (Fig. 5). In contrast, under ambient room light, some 
vascular relaxation was noted at [1] = 10-6 M, while full relaxation was verified when [1] equaled 
10-5 M. However, when a 10-5 M solution of 1 was added directly to fresh, fully contracted aortic 
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rings under ambient light (SI Fig. S-5), full relaxation was slow, requiring ~50 min, owing to the 
correspondingly slow photoreaction under these conditions.  In the absence of light, very little  
 
Figure 4. Cell viability plots in different concentrations of compound 1 (Ru(salenCO2H)(NO)Cl). Cell viability as 
assessed by the MTT assay (see Experimental).  The results show cell survival relative to the control (absence of 1). 
The values are the mean ± SEM. * p < 0.05 in comparison to others treatments and the control obtained by ANOVA 
analyses using Tukey’s pos test. The plates under light were irradiated for 4 min at 470 nm (4 J/cm2) at the beginning 
of the experiment. 
 
Figure 5. Vascular relaxation induced by Ru(NO)(salenCO2H)Cl (1) in denuded rat aortic rings in ambient light or in 
the dark. Data are mean ± SEM (n=6). 

















relaxation was observed, again consistent with the vasodilation process generally being triggered 
by the activation of the very sensitive enzyme guanylyl cyclase [31]. The areas under these curves 
were used to calculate the relative relaxation induced by 1 over 60 min in the dark and under 
ambient light (SI Fig. S3). Notably, for the latter experiment, there was little significant difference 
in the responses seen for thoracic aortas with their endothelium intact vs. those that have been 
denuded. Thus, the vascular dilation observed under ambient light can be attributed to the NO 
released by photolabilization from the ruthenium nitrosyl and not by residual NO from endogenous 
production in the system.  
 Chemical and electrochemical reduction:  Ruthenium nitrosyl complexes have also been 
shown to release NO upon one electron reduction (Eq. 4) [44].  This type of release was tested 
with Ru(salenCO2H)(NO)Cl electrochemically, and it was found that in order to induce the pro-
duction of NO, 1 required a charging potential at –0.5 V vs Ag/AgCl. Differential pulse voltam-
mograms of 1 in aqueous solution shows the peak at –0.3 V vs Ag/AgCl attributed to {Ru-NO}2+/3+ 
oxidation after such charging.  The initial reduction with similar systems has been identified as 
centered on the nitrosyl ligand, which can be represented as follows:  RuII(NO+) + e–  à RuII(NO•) 
[44]. Pre-treatment at –0.5 V causes the decrease in the peak intensity at –0.3 V (Fig. 6) consistent 
with labilization of the NO ligand upon reduction of 1 (Eq. 4). A second peak at ~ 0.1 V vs 
Ag/AgCl appears after the reduction process, which was attributed to the oxidation of the aquo 
species Ru(salenCO2H)(H2O)Cl, [1-H2O]3–, which is formed upon NO labilization from reduced 
1. Thermal release of NO from reduced 1 was qualitatively confirmed by using a NO specific 
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Figure 6. Differential pulse voltammetry scans with carbon glass electrode with Ag/AgCl reference electrode of 
Ru(salenCO2H)(NO)Cl (1). Scans recorded after specified timed charging with conditioning potential of -0.5 V and 
run between –0.5  and  0.5 V. 
electrode (SI Fig. S4).  The time dependence of the scans in Figure 5 as well as for the formation 
of free NO  suggest that thermal release of NO from the reduced 1 (Eq. 4) has a half-life of sev-
eral hundred seconds.     
    (4) 
  The addition of ascorbate (0.14 M) to a solution of 1 (28 µM) in pH 7.4 phosphate buffer 
also triggers NO release as demonstrated using the NO specific electrode system (SI Fig. S-6).  
 
Summary: 
This study has described a photo-activated NO releasing moiety Ru(salenCO2H)(NO)Cl 
(1) that is stable in aerobic aqueous solutions while displaying pH dependent quantum yields for 
NO generation in vitro.  This complex was shown to stimulate vasodilation in mammalian aortic 
rings specifically when exposed to ambient light. The pH dependent quantum yields can be at-
tributed to the nitrosyl / N-nitrito equilibrium that results in enhanced NO release at lower pH.  
Such an effect suggests a strategy for targeting NO release in the relative acidic environment char-
acteristic of hypoxic tumors [45,46]. Neither the photoNORM precursor nor the small amount of 
NO released is cytotoxic, but the photo-induced NO release, even with a very modest quantum 
yield, would be sufficient to trigger soluble guanylyl cyclase mediated vasodilation [47], thereby 
increasing circulation to and oxygenation of the targeted tissues.  If this process were coupled to 
radiotherapy, the increased oxygenation would enhance the sensitivity of the targeted tissues to 
radiation-induced cell death.  Similarly, such targeted NO release leading to enhanced circulation 
could synergistically enhance the efficacy of chemotherapy.   
Nonetheless, a realistic evaluation of the present system has to take into consideration that 
the short wavelength necessary to trigger NO release from 1 would have poor penetration through 
living tissue. For this reason, strategies that can utilize tissue penetrating near infrared (NIR) light  
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such the use of antennas such as upconverting nanoparticles that can be activated by multiphoton 
NIR excitation need to be employed.  Notably, the pendant carboxylate groups of 1 besides provid-
ing aqueous solubility, also provide ample opportunity for further conjugation with groups like 
cell-targeting peptide [48] or with antennas such as nanomaterials with desirable photophysical 
properties [13,49]. These studies are ongoing.  
 
Experimental Section. 
 Materials: Trichloridonitrosylruthenium(III) monohydrate, Ru(NO)Cl3•H2O was pur-
chased from Strem Chemicals Inc. Other synthetic materials including trifluoroacetic acid, 4-hy-
droxybenzoic, hexamethylenetetramine, 95% sodium hydride and laboratory solvents were pur-
chased from Sigma-Aldrich. Cell lines, media, and MTT assay reagents for cell toxicity studies 
were provided by the Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de 
São Paulo.  All buffers used for quantum yield measurements were prepared in nanopure water at 
50 mM concentrations. The pH was adjusted to exact values using dilute NaOH or HCl as required. 
Phosphate buffers were prepared for pH values 11.0, 7.4, 6.0, and 4.5 while tris(hydroxyme-
thyl)aminomethane (Tris) was used to prepare the pH 9.0 buffer.  
 Synthesis of Ru(salen-CO2H)(NO)Cl (1).  The salen-CO2H ligand (3) was prepared ac-
cording to the reaction sequence outlined in Scheme 1 from salicylaldehyde-4-carboxylic acid (2), 
which was synthesized according to published procedures [50] (See SI). The nitrosyl complex 
chloridonitrosyl(N,N’-ethylenebis(3,3’-bis-carboxylsalicylidene-iminato)ruthenium(III) (1) was 
prepared from 3 as follows.  A mixture of 3 (0.50 g, 1.41 mmoles), sodium hydride (0.107 g, 4.45 
mmoles), and trichloridonitrosylruthenium(III) monohydrate, Ru(NO)Cl3•H2O, (0.317 g, 1.41 
mmoles) was added to a three neck 300 mL round bottom flask and placed under an argon atmos-
phere.  Approximately 150 mL of deaerated ethanol was then transferred via cannula into the re-
action flask. The resulting solution was refluxed under argon in the dark for 4 h, after which it was 
allowed to cool to room temperature, and the ethanol was removed via rotary evaporation. The 
sodium chloride byproduct was removed from the desired product by washing the solid with water 
adjusted to pH 5 with dilute HCl. The remaining solid was dried under vacuum for several hours 
(Scheme 1, step iii) (89% Yield). 1H NMR (DMSO-d6):  δ 8.69ppm (1H, s) aldimine protons, 8.02 
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(1H, s), 7.85 (1H, d), 6.83 (1H, d) phenyl protons, 3.94 (2H, s) ethylene bridge. Analysis: Theore-
tical for [Ru(salenCO2H)(NO)Cl]•2H2O (C18H16N3O7ClRu•2H2O): C, 38.68%; H, 3.61%; N, 
7.52%.  Found: C, 38.3%; H, 3.43%, N 7.59%. FTIR (KBr) nNO = 1865 cm-1. UV-vis (pH 7.4 in 
50 mM phosphate buffer): lmax 248 nm (e = 3.8 x 104 M-1 cm-1), 359 (e = 6.6 x 103 M-1 cm-1).  
 Once the product was washed with the pH 5 solution, solubility for aqueous solution ex-
periments was achieved by dissolving the compound into a solution above pH 9. These stock so-
lutions were then diluted into buffered media for spectroscopic studies or for investigation with 
murine tissues or cells. 
 Quantum yield measurements: NO release was measured using a GE model NOA 280i Sievers 
Nitric Oxide Analyzer (NOA) calibrated per the manufacturer's specifications. This device quan-
titatively measures the NO present in a carrier gas, which is either helium or medical grade air, 
that is entrained through the photolysis solution [51]. The carrier gas was first passed through a 
glass chamber containing only solvent prior to entering the reaction cell in order to prevent evap-
orative solvent loss and to maintain a constant volume in the reaction cell throughout the experi-
ment. Quantum yield measurements at the pH values at 4.5, 6.0, 7.4, 9.0, and 11.0 were conducted 
individually using a stock solution of 1. The cuvette was filled with 3 mL of pH-adjusted solutions 
of 1 and entrained with carrier gas for 5 min, in order to allow the NOA establish a stable baseline. 
The photolysis was conducted at lirr 365 nm with the light from a high-pressure mercury lamp 
passed through a narrow band pass interference filter or at lirr 470 nm with a blue LED from 
Luxeon. The intensity of the excitation at 365 nm was determined using ferrioxolate actinometry 
[52], and the intensity of the LED light was measured with a Newport power meter. Individual 
samples were irradiated for varied time intervals controlled by a Uniblitz shutter and the photo-
chemically released NO was recorded using the NOA software “Liquid”. The plotted slope is FNO 
(see Fig. 3).  
 pKa measurements: The pH dependent changes in UV-visible spectrum of 1 were rec-
orded in order to examine the acid/base dependent equilibria. In order to determine these quanti-
tatively, compound 1 was dissolved in slightly basic water and diluted to a concentration of 0.15 
mM in 50 mM KCl solution. The pH was adjusted by adding small increments of dilute hydro-
chloric acid and determined with a pH meter. After the pH stabilized, the UV-visible spectrum 
was recorded.  This was done for ~100 different pH values from 0.5 to 11. 
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 Cell viability studies: The cytotoxicity activity of 1 was evaluated against B16F10 murine 
melanoma cells using the colorimetric method with 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenylte-
trazolium bromide (MTT assay) [43]. The cells were cultured in Roswell Park Memorial Institute 
1640 medium (RPMI) enriched with 2% fetal bovine serum, seeded into 96-well plates (2 × 105 
cells/well) and incubated according to published procedures [53]. Stock solutions of 1 were pre-
pared in concentrations of 20 mM, 10 mM, 2 mM, and 1 mM, and 2 µL aliquots of these solutions 
were added to each well to obtain a total volume of 200 µL of media. The final concentrations of 
1 in the wells were 200 µM, 100 µM, 20 µM, 10 µM, and 0 µM (control). The cells were incubated 
with 1 in the dark for 4 h in the RPMI medium (pH 7.2). Phenol red indicator was not used in the 
media during the photolysis to avoid light being absorbed by this indicator. Half of the cell plates 
were irradiated with 470 nm light for 4 min with a modified cell plate LED, and all plates were 
then incubated for either 24 or 48 h.  After the incubation, the media was removed and 200 µL 
MTT solution (0.5 mg/mL RPMI medium) was added to each well and incubated for 3 h. MTT is 
converted into crystals by the viable cells. To solubilize the product, the medium was removed and 
200 µL of DMSO was added into the wells. (MTT solution; 12 mM thiazolyl blue tetrazolium 
bromide in phosphate buffer was diluted in media to a final concentration of 1.2 mM.) The absorb-
ance was recorded by a Thermo Plate leitora de microplaca TP-reader plate reader at 570 nm.  The 
reported values are an average of triplicate samples in three different experiments. The data was 
normalized to the control wells, not containing compound 1. Data was compiled and processed 
using Prism 5.0 software.  
 Vascular dilation studies: All the procedures were performed in accordance with the 
standards and policies of Animal Care and Use Committee of the University of São Paulo. Male 
rats (180-200 g) were sacrificed by decapitation under anesthesia. The thoracic aorta was quickly 
removed, and cut into rings (4-5 mm length). The endothelium was mechanically removed from 
one of the two rings by gently rolling the lumen of the vessel on a thin wire. Aortic rings with 
and without endothelium cells were studied concurrently. The aortic rings were placed between 
two stainless-steel stirrups and connected to an isometric force transducer (Letica Scientific In-
struments, Barcelona–Spain) to measure tension in the vessels. The rings were placed in an organ 
chamber containing Krebs solution with the following composition (mM): NaCl (130.0), KCl 
(4.7), KH2PO4 (1.2), MgSO4 (1.2), NaHCO3 (14.9), glucose (5.5) and CaCl2 (1.6). The solution 
was maintained at pH 7.4 and bubbled with a gas mixture of 95% O2 and 5% CO2 at 37 °C. The 
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rings were initially stretched to a basal tension of 1.5 g and allowed to equilibrate for 60 min. 
The presence of endothelium was evaluated by the degree of relaxation induced by acetylcholine 
(1 µM) in the presence of contractile tone induced by phenylephrine (PE, 0.1 µM). Endothelium-
intact arteries were discarded if relaxation with acetylcholine was not greater than 80% while en-
dothelium-denuded arteries were discarded if there was degree of relaxation for acetylcholine 
higher than 10%. The rings were then washed and pre-contracted with 10 µL of PE (0.1 µM). 
After stabilized contraction, two tests for vascular relaxation were separately conducted using 
compound 1: the concentration-effect curve and the time course with the necessary concentration 
to induce maximum vascular relaxation. For the concentration-effect curve, stock solutions from 
0.1 µM - 5 mM were prepared and cumulatively added in sequence to the Krebs buffered organ 
chambers. The final concentration ranged from 10-10 M to 10-4 M (Figure 4). The time course for 
compound 1 induced relaxation was monitored over the course of an hour following the single 
administration of 20 µL of 5 mM 1 for a final concentration of 10-5 M. (Figure 5). Both experi-
ments were conducted in ambient light or dark. The comparisons between groups were assessed 
by student t-test. The level of statistical significance was defined as P<0.05. 
 Voltammetric studies: The electrochemical study was performed with an AUTOLAB 
PGSTAT 30 model potentiostat galvanostat consisting of a conventional three electrode cell with 
a platinum wire auxiliary electrode, an Ag/AgCl reference electrode, and a glassy carbon work-
ing electrode. An aqueous 0.1 M KCl solution was used as the supporting electrolyte. The solu-
tion was charged at -0.5 V for a period of 0 and 300 s prior to scanning from -0.5 V- 0.5 V. Ad-
ditionally, negative scan was charged at 0.3 then run over from 0.3 - -0.5 V. 
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lirr:  wavelength of irradiation 
MTT:  3-(4,5-dimethylthiazol-2-yl)-2,5-ditetrazolium bromide 
NIR: near infrared 
NOA: Sievers Nitric Oxide Analyzer 
PE: phenylephrine 
photoNORM: photo-activated nitric oxide releasing moiety 
ΦNO: quantum yield for nitric oxide release 
RPMI medium:  Roswell Park Memorial Institute 1640 medium  
salenCO2H:  N,N'-ethylenebis(3,3’-bis-carboxyl-salicylidene-iminato 
SI:  supporting information 
UV-vis:  ultraviolet-visible 
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The water-soluble photochemical nitric oxide (NO) precursor Ru(salen-CO2H)(NO)Cl (salen-
CO2H = N,N'-ethylenebis(3,3’-bis-carboxylsalicylideneiminato) displays a pH dependent quan-
tum yield owing to the nitrosyl/ N-nitrito equilibrium of the axial ligand.   
 
